HeaIgen Scientific Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • HeaIgen Scientific's estimated annual revenue is currently $11.2M per year.(i)
  • HeaIgen Scientific's estimated revenue per employee is $155,000

Employee Data

  • HeaIgen Scientific has 72 Employees.(i)
  • HeaIgen Scientific grew their employee count by 41% last year.

HeaIgen Scientific's People

NameTitleEmail/Phone
1
Chief Marketing OfficerReveal Email/Phone
2
VP ProcurementReveal Email/Phone
3
SalesReveal Email/Phone
4
PresidentReveal Email/Phone
5
Sales RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is HeaIgen Scientific?

Healgen Scientific specializes in manufacturing quality immunoassay tests. Since our inception in 2007, we have strived to develop devices that meet and exceed industry standards. The manufacturing process is supported by our interactive and highly-skilled Research and Development team, who are actively redefining the efficiency and design of our products. Our ambition is worldwide, and we currently provide products to customers in: USA, Europe, Middle-East, South Asia, Africa and Latin America for a total of 80+ countries. Our mission is to provide premier support to our distributors and partners. We have a flexible strategy on business cooperation, where we offer OEM options. Our success is supported by our professional personnel and good manufacturing practice; we will always offer the best quality and services to our customers.

keywords:N/A

N/A

Total Funding

72

Number of Employees

$11.2M

Revenue (est)

41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.4M72-5%N/A
#2
$15.9M72-5%N/A
#3
$17.5M720%N/A
#4
$17.2M7211%N/A
#5
$12.2M72-9%N/A